Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
Type
Private
HQ
Cambridge, US
Founded
2008
Size (employees)
72 (est)
Constellation Pharmaceuticals was founded in 2008 and is headquartered in Cambridge, US
Report incorrect company information

Key People/Management at Constellation Pharmaceuticals

Jigar Raythatha

Jigar Raythatha

President & Chief Executive Officer
Matthias Jaffe

Matthias Jaffe

CFO
Mark A. Goldsmith

Mark A. Goldsmith

Executive Chairman
James Audia

James Audia

Chief Scientific Officer
Brenda Sousa

Brenda Sousa

Vice President of Human Resources

Constellation Pharmaceuticals Office Locations

Constellation Pharmaceuticals has an office in Cambridge
Cambridge, US (HQ)
215 First St
Show all (1)
Report incorrect company information

Constellation Pharmaceuticals Financials and Metrics

Summary Metrics

Constellation Pharmaceuticals's latest funding round in April 2018 was reported to be $100 m. In total, Constellation Pharmaceuticals has raised $309.5 m
Show all financial metrics
Report incorrect company information

Constellation Pharmaceuticals Online and Social Media Presence

Embed Graph
Report incorrect company information